Publication | Closed Access

Nanovaccine’s rapid induction of anti-tumor immunity significantly improves malignant cancer immunotherapy

NanomedicineNanovaccine ’Tumor ImmunologyCancer ImmunosurveillanceRapid InductionImmunologyTumor ImmunityTherapeutic VaccineAnti-tumor ImmunityCancer VaccinesTumor TargetingImmune Cell TherapyImmunotherapyMedicineRadiation Oncology